autoimmune disease and semaglutide Association between diseases glucagon-like peptide-1 receptor agonists: A real-world evidence study Microdosing GLP-1 for autoimmune conditions:

Results are reviewed by your provider and can inform dose adjustments or identify potential side effects early

Fatigue is one of the side effects that some individuals experience when starting semaglutide

Studies support the role of GLP-1 in paracrine regulationincrease in pancreatic insulin secretion and decrease in glucagon secretion leading to non-hepatic skeletal muscle glucose disposal (uptake) in the initial prandial state and increased hepatic glucose disposal in the postprandial state [32]

Kamiya et al

For this reason, gastroenterologists and weight loss specialists typically recommend staying on the medication until you achieve your target weight and have developed sustainable eating habits

Gerbe, F., Legraverend, C